News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Trodelvy (Sacituzumab Govitecan (IMMU-132)
September 2, 2025
Update on Strategies to Improve Treatment for Triple Negative Breast Cancer
Charles H. Weaver, MD
September 14, 2023
Anti-TROP-2 Antibody Drug Conjugate Trodelvy Evaluated in Non-Small Cell Lung Cancer
Charles H. Weaver, MD
February 4, 2023
Trodelvy for HR+/HER2– Metastatic Breast Cancer
Charles H. Weaver, MD
November 13, 2020
Treatment of Stage IV – Metastatic Breast Cancer
Charles H. Weaver, MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
